Ronald A Bronicki1, Mark Hall. 1. 1Department of Pediatrics, Section of Critical Care Medicine and Cardiology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX. 2Department of Pediatrics, Section of Critical Care Medicine, Ohio State College of Medicine, Nationwide Children's Hospital, Columbus, OH.
Abstract
OBJECTIVES: The objectives of this review are to discuss the pathophysiology of the pro-inflammatory response to the cardiopulmonary bypass circuit, the impact of ischemia reperfusion injury on post-operative organ function, the compensatory anti-inflammatory response and the evidence for immune-modulatory strategies and their impact on outcomes. DATA SOURCE: MEDLINE, PubMed. CONCLUSION: Innovations such as the development of more biocompatible surfaces and miniaturized circuits, as well as the increasing expertise of surgeons, anesthesiologists and perfusionists has transformed cardiac surgery and the use of cardiopulmonary bypass into a relatively routine procedure with favorable outcomes. Despite these refinements, the attendant inflammatory response to bypass, ischemia reperfusion injury and the compensatory anti-inflammatory response contribute to post-operative morbidity and mortality. Additional studies are needed to further delineate the impact of immunomodulatory strategies on outcomes.
OBJECTIVES: The objectives of this review are to discuss the pathophysiology of the pro-inflammatory response to the cardiopulmonary bypass circuit, the impact of ischemia reperfusion injury on post-operative organ function, the compensatory anti-inflammatory response and the evidence for immune-modulatory strategies and their impact on outcomes. DATA SOURCE: MEDLINE, PubMed. CONCLUSION: Innovations such as the development of more biocompatible surfaces and miniaturized circuits, as well as the increasing expertise of surgeons, anesthesiologists and perfusionists has transformed cardiac surgery and the use of cardiopulmonary bypass into a relatively routine procedure with favorable outcomes. Despite these refinements, the attendant inflammatory response to bypass, ischemia reperfusion injury and the compensatory anti-inflammatory response contribute to post-operative morbidity and mortality. Additional studies are needed to further delineate the impact of immunomodulatory strategies on outcomes.
Authors: Lihua Ao; Yufeng Zhai; Chunhua Jin; Joseph C Cleveland; David A Fullerton; Xianzhong Meng Journal: Mol Med Date: 2016-12-19 Impact factor: 6.354
Authors: I Djordjevic; K Eghbalzadeh; S Heinen; G Schlachtenberger; S Gerfer; A Sabashnikov; J Merkle; C Weber; E Kuhn; M Zeriouh; P Rahmanian; N Mader; O-J Liakopoulos; T Wahlers Journal: World J Surg Date: 2020-01 Impact factor: 3.352
Authors: Michael Robich; Sergey Ryzhov; Doreen Kacer; Monica Palmeri; Sarah M Peterson; Reed D Quinn; Damien Carter; Forest Sheppard; Timothy Hayes; Douglas B Sawyer; Joseph Rappold; Igor Prudovsky; Robert S Kramer Journal: J Surg Res Date: 2020-04-30 Impact factor: 2.192
Authors: Zühre Uz; Güçlü Aykut; Michael Massey; Yasin Ince; Bülent Ergin; Lucinda Shen; Fevzi Toraman; Thomas M van Gulik; Can Ince Journal: J Vasc Res Date: 2019-09-10 Impact factor: 1.934
Authors: Amanda C Becker; Connor W Lantz; Joseph M Forbess; Conrad L Epting; Edward B Thorp Journal: Pediatr Crit Care Med Date: 2021-09-01 Impact factor: 3.971
Authors: Lindsay E Volk; Constantine D Mavroudis; Tiffany Ko; Thomas Hallowell; Nile Delso; Anna L Roberts; Jonathan Starr; William Landis; Yuxi Lin; Marco Hefti; Ryan W Morgan; Richard W Melchior; Tami M Rosenthal; Alexander Chappell; Douglas Fisher; Molly Dreher; Daniel J Licht; Jonathan Chen; J William Gaynor; Christopher E Mascio; Todd J Kilbaugh Journal: Eur J Cardiothorac Surg Date: 2021-06-14 Impact factor: 4.191